Martin Teall

458 total citations
17 papers, 338 citations indexed

About

Martin Teall is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Martin Teall has authored 17 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Organic Chemistry. Recurrent topics in Martin Teall's work include Chemical Synthesis and Analysis (3 papers), Neuroscience and Neuropharmacology Research (3 papers) and Alzheimer's disease research and treatments (3 papers). Martin Teall is often cited by papers focused on Chemical Synthesis and Analysis (3 papers), Neuroscience and Neuropharmacology Research (3 papers) and Alzheimer's disease research and treatments (3 papers). Martin Teall collaborates with scholars based in United Kingdom, United States and China. Martin Teall's co-authors include Walter Gibson, Euan R. Kay, Mark S. Shearman, Duncan Shaw, Timothy Harrison, José L. Castro, Paul Oakley, Ute Gerhard, Richard G. Ball and Nancy N. Tsou and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Food and Chemical Toxicology.

In The Last Decade

Martin Teall

17 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Teall United Kingdom 8 151 89 76 69 46 17 338
Hoh‐Gyu Hahn South Korea 15 423 2.8× 187 2.1× 42 0.6× 33 0.5× 57 1.2× 60 737
Jed L. Hubbs United States 11 324 2.1× 136 1.5× 85 1.1× 21 0.3× 80 1.7× 19 502
Zhi-Qiang Yang United States 5 191 1.3× 201 2.3× 44 0.6× 82 1.2× 51 1.1× 5 442
Jill M. Wetter United States 15 152 1.0× 316 3.6× 139 1.8× 118 1.7× 42 0.9× 22 646
T. Ladduwahetty United States 11 339 2.2× 288 3.2× 55 0.7× 92 1.3× 37 0.8× 15 642
Laxmikant A. Gharat India 12 151 1.0× 148 1.7× 62 0.8× 29 0.4× 89 1.9× 29 472
John V. Mulcahy United States 8 258 1.7× 191 2.1× 65 0.9× 46 0.7× 24 0.5× 12 430
Ichiro Hijikuro Japan 11 150 1.0× 141 1.6× 101 1.3× 19 0.3× 92 2.0× 24 401
Fanny Astruc‐Diaz United States 9 100 0.7× 144 1.6× 74 1.0× 158 2.3× 189 4.1× 12 421
Stanley DiDomenico United States 14 251 1.7× 177 2.0× 23 0.3× 84 1.2× 23 0.5× 14 473

Countries citing papers authored by Martin Teall

Since Specialization
Citations

This map shows the geographic impact of Martin Teall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Teall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Teall more than expected).

Fields of papers citing papers by Martin Teall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Teall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Teall. The network helps show where Martin Teall may publish in the future.

Co-authorship network of co-authors of Martin Teall

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Teall. A scholar is included among the top collaborators of Martin Teall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Teall. Martin Teall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bürli, Roland W., Kevin Doyle, Louise Dickson, et al.. (2024). Discovery of CVN293, a Brain Permeable KCNK13 (THIK-1) Inhibitor Suitable for Clinical Assessment. ACS Medicinal Chemistry Letters. 15(5). 646–652. 2 indexed citations
2.
Brice, Nicola, Louise Dickson, Martin Teall, et al.. (2023). Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction. Journal of Medicinal Chemistry. 66(17). 11718–11731. 3 indexed citations
3.
Doyle, Kevin, Xiao Xu, Louise Dickson, et al.. (2023). Discovery and Characterization of Novel CNS-Penetrant GPR55 Agonists. Journal of Medicinal Chemistry. 66(18). 12858–12876. 3 indexed citations
4.
Patel, Ryan, Robert G. Newman, Feng Jiang, et al.. (2014). Novel TRPM8 Antagonist Attenuates Cold Hypersensitivity after Peripheral Nerve Injury in Rats. Journal of Pharmacology and Experimental Therapeutics. 349(1). 47–55. 26 indexed citations
5.
Teall, Martin, Paul Oakley, Timothy Harrison, et al.. (2005). Aryl sulfones: a new class of γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(10). 2685–2688. 98 indexed citations
6.
Churcher, Ian, Dirk Beher, Jonathan D. Best, et al.. (2005). 4-Substituted cyclohexyl sulfones as potent, orally active γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(2). 280–284. 61 indexed citations
7.
Churcher, Ian, Kate Ashton, John W. Butcher, et al.. (2003). A new series of potent benzodiazepine γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(2). 179–183. 47 indexed citations
8.
Harrison, Timothy, Janusz J. Kulagowski, Paul D. Leeson, et al.. (1997). 4-Heterocyclyl tetrahydropyridines as selective ligands for the human dopamine D4 receptor. Bioorganic & Medicinal Chemistry Letters. 7(17). 2211–2216. 2 indexed citations
9.
Swain, Christopher J., Eileen M. Seward, Margaret A. Cascieri, et al.. (1996). ChemInform Abstract: Identification of a Series of 3‐(Benzyloxy)‐1‐azabicyclo(2.2.2)octane Human NK1 Antagonists.. ChemInform. 27(14). 1 indexed citations
10.
Teall, Martin, Timothy Harrison, Jonathan D. Moseley, et al.. (1996). Linear amides as substance P antagonists. Bioorganic & Medicinal Chemistry Letters. 6(13). 1585–1588. 4 indexed citations
11.
Williams, Brian J., Martin Teall, Timothy Harrison, et al.. (1994). Acyclic NK-1 antagonists: 2-benzhydryl-2-aminoethyl ethers. Bioorganic & Medicinal Chemistry Letters. 4(16). 1903–1908. 24 indexed citations
12.
Swain, Christopher J., Margaret A. Cascieri, Andrew P. Owens, et al.. (1994). Acyclic NK1 antagonists: Replacements for the benzhydryl group.. Bioorganic & Medicinal Chemistry Letters. 4(18). 2161–2164. 11 indexed citations
13.
Fletcher, Stephen R., et al.. (1993). 4-hydroxyphenoxymethylene bisphosphonic acid derivatives: potent, non-hydrolysable inhibitors of MYO-inositol monophosphatase. Bioorganic & Medicinal Chemistry Letters. 3(2). 141–146. 6 indexed citations
14.
Fletcher, Stephen R., et al.. (1992). Inhibitors of myo-inositol monophosphatase unrelated to the enzyme substrate. Bioorganic & Medicinal Chemistry Letters. 2(6). 627–630. 7 indexed citations
15.
Teall, Martin, et al.. (1987). A novel synthesis of substituted 3-aminopenems. Tetrahedron Letters. 28(20). 2283–2286. 2 indexed citations
16.
Gibson, Walter & Martin Teall. (1983). Interactions of C12 surfactants with the skin: Changes in enzymes and visible and histological features of rat skin treated with sodium lauryl sulphate. Food and Chemical Toxicology. 21(5). 587–594. 24 indexed citations
17.
Gibson, Walter & Martin Teall. (1983). Interactions of C12 surfactants with the skin: Studies on enzyme release and percutaneous absorption in vitro. Food and Chemical Toxicology. 21(5). 581–586. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026